Bafna Pharmaceuticals Limited
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Bafna Pharmaceuticals Limited's balance sheet done over the years? Its assets were worth $1,476,816,000 last year, which is more than in the previous period. 45% of Bafna Pharmaceuticals Limited’s total assets is currently financed by debt. Its liabilities reached the amount of $668,426,000, which means an increase by 144% compared compared to last year.
Debt to Assets
| 2011 | 1356212736 | 814.32M | 60.04% |
|---|---|---|---|
| 2012 | 2189397410 | 1.54B | 70.49% |
| 2015 | 1998292280 | 1.27B | 63.61% |
| 2016 | 1925246770 | 1.34B | 70.1% |
| 2018 | 1383624000 | 1.01B | 73.11% |
| 2019 | 1194721000 | 1.00B | 84.22% |
| 2020 | 713126000 | 201.17M | 28.21% |
| 2021 | 864659000 | 296.94M | 34.34% |
| 2022 | 902444000 | 273.64M | 30.32% |
| 2024 | 1476816000 | 668.42M | 45.26% |
BAFNAPH.NS Balance Sheet (2011 – 2023)
| 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 13.96M | 194K | 7.47M | 81.85M | 1.39M | 5.01M | 27.13M | 27.70M | 24.64M | 117.79M |
Short term investments | 6.99M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net receivables | 453.94M | 149.33M | 106.15M | 134.57M | 389.32M | 242.79M | 822.37M | 0 | 0 | 0 |
Inventory | 296.41M | 202.80M | 154.43M | 114.11M | 92.82M | 106.74M | 163.79M | 161.22M | 239.18M | 147.47M |
Other current assets | 180.37M | 161.65M | 228.61M | 164.98M | 1.14M | 108.34M | 392.09M | 1.08B | 1.10B | 610.47M |
Total current assets | 944.69M | 513.98M | 496.68M | 360.95M | 484.69M | 487.39M | 1.22B | 1.27B | 1.36B | 875.74M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 507.07M | 388.45M | 367.97M | 351.81M | 370.19M | 448.60M | 525.70M | 545.25M | 557.80M | 470.41M |
Goodwill | 0 | 0 | 0 | 358K | 358K | 358K | 358.03K | 358.03K | 358.03K | 0 |
Intangible assets | 17.7M | 0 | 0 | 0 | 358K | 0 | 358.03K | 0 | 204.24M | 0 |
Long term investments | 0 | 0 | 0 | 0 | 0 | 0 | 169M | 169M | 0 | 0 |
Other non-current assets | 7.34M | -3K | -2K | -2K | 339.48M | 447.27M | 176.16M | 181.79M | 60.81M | 10.05M |
Total non-current assets | 532.11M | 388.45M | 367.97M | 352.16M | 710.03M | 896.23M | 702.23M | 727.41M | 823.21M | 480.46M |
Total assets | 1.47B | 902.44M | 864.65M | 713.12M | 1.19B | 1.38B | 1.92B | 1.99B | 2.18B | 1.35B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 6.85M | 9.67M | 25.09M | 33.98M | 46.35M | 81.35M | 0 | 0 | 0 |
Short term debt | 136.36M | 11.50M | 105M | -25.09M | 232.39M | 188.44M | 453.07M | 570.13M | 0 | 0 |
Total current liabilities | 540.83M | 163.89M | 243.08M | 170.99M | 708.20M | 598.46M | 950.45M | 1.11B | 1.22B | 275.67M |
| Non-current liabilities: | ||||||||||
Long term debt | 107.53M | 78.92M | 52.86M | 30.17M | 229.88M | 232.49M | 351.71M | 116.40M | 263.30M | 510.47M |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28.17M |
Other non-current liabilities | 20.06M | 30.82M | 1.00M | -30.17M | 6.32M | 129.52M | 47.36M | 3.9M | 0 | 0 |
Total non-current liabilities | 127.59M | 109.74M | 53.86M | 30.17M | 297.99M | 413.13M | 399.08M | 160.30M | 315.80M | 538.65M |
Total liabilities | 668.42M | 273.64M | 296.94M | 201.17M | 1.00B | 1.01B | 1.34B | 1.27B | 1.54B | 814.32M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |